Diagnostic significance of alanine aminotransferase isoenzymes in alcoholic and non-alcoholic fatty liver cancers

被引:1
作者
Zhou, Dandan [1 ,2 ]
Yuan, Zuowei [1 ]
Shu, Xiaoqin [1 ]
Tang, Hejun [1 ]
Li, Jie [1 ]
Ye, Yangmin [1 ]
Tao, Nana [1 ]
Zhou, Fangzhu [1 ]
Zhang, Jun [3 ,4 ]
Zheng, Jian [3 ,4 ]
Wu, Qian [5 ]
Zhang, Juan [1 ,2 ]
机构
[1] Chongqing Hosp Tradit Chinese Med, Dept Clin Lab, Chongqing, Peoples R China
[2] Chongqing Hosp Tradit Chinese Med, Lab Diag & Treatment Infect Dis Integrated Tradit, Chongqing, Peoples R China
[3] Artron BioRes Inc, 3938 North Fraser Way, Burnaby, BC, Canada
[4] Jinan Kangbo Biotechnol, 2711 Ying Xiu Rd, Jinan, Shandong, Peoples R China
[5] Chongqing Med Univ, Affiliated Hosp 2, Dept Lab Med, 74 Linjiang Rd, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
POPULATION; EXPRESSION; CLONING; INJURY;
D O I
10.1042/BSR20230222
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objectives: Alanine aminotransferase (ALT) expression is highly elevated in the serum of patients with hepatocellular carcinoma. However, the role of ALT isoenzymes in the total ALT activity remains unclear. In the present study, we systematically investigated the role of ALT isoenzymes in alcoholic and non-alcoholic fatty liver cancer. Materials and methods: The expression of ALT1 and ALT2 at the mRNA and protein levels in 25 paired primary liver cancer tissues was detected by reverse transcription quantitative PCR (RT-qPCR), West-ern blotting, and immunohistochemistry. Serum ALT activity was determined using an au-tomated biochemical analyzer. Results: The mRNA and protein expression levels of ALT1 and ALT2 were lower in the tissues of alcoholic and non-alcoholic fatty liver cancers than in the paracancerous tissues. Notably, ALT2 was highly expressed in non-alcoholic fatty liver cancer tissues compared with alcoholic fatty liver cancer tissues. Total serum ALT activity was mainly contributed by ALT1 in alcoholic fatty liver cancer, whereas ALT1 contributed only marginally more to the total ALT activity than ALT2 in non-alcoholic fatty liver can-cer. ALT2/ALT1 ratio can well discriminate normal control group, alcoholic liver cancer and non-alcoholic liver cancer. Conclusion: ALT1 contributed more to the total ALT activity than ALT2 in both alcoholic and non-alcoholic fatty liver cancer. Serum ALT2 to ALT activity was higher in non-alcoholic fatty liver cancer than that in alcoholic fatty liver cancer. ALT2/ALT1 ratio has some diagnostic significance for alcoholic and non-alcoholic liver cancer.
引用
收藏
页数:9
相关论文
共 36 条
  • [31] Alanine Aminotransferase Isoenzymes: Molecular Cloning and Quantitative Analysis of Tissue Expression in Rats and Serum Elevation in Liver Toxicity
    Yang, Rong-Ze
    Park, Soohyun
    Reagan, William J.
    Goldstein, Rick
    Zhong, Shao
    Lawton, Michael
    Rajamohan, Francis
    Qian, Kun
    Liu, Li
    Gong, Da-Wei
    [J]. HEPATOLOGY, 2009, 49 (02) : 598 - 607
  • [32] cDNA cloning, genomic structure, chromosomal mapping, and functional expression of a novel human alanine aminotransferase
    Yang, RZ
    Blaileanu, G
    Hansen, BC
    Shuldiner, AR
    Gong, DW
    [J]. GENOMICS, 2002, 79 (03) : 445 - 450
  • [33] RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer
    Yang, Yueyue
    Lin, Jiafei
    Guo, Susu
    Xue, Xiangfei
    Wang, Yikun
    Qiu, Shiyu
    Cui, Jiangtao
    Ma, Lifang
    Zhang, Xiao
    Wang, Jiayi
    [J]. CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [34] Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer
    Zhai, Xiuming
    Yang, Zhaowei
    Liu, Xiji
    Dong, Zihe
    Zhou, Dandan
    [J]. PEERJ, 2020, 8
  • [35] Changing epidemiology of hepatocellular carcinoma in Asia
    Zhang, Chen-hao
    Cheng, Yifei
    Zhang, Shu
    Fan, Jia
    Gao, Qiang
    [J]. LIVER INTERNATIONAL, 2022, 42 (09) : 2029 - 2041
  • [36] Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC
    Zhao, Zhifeng
    Zhu, Yiming
    Ni, Xiaochun
    Lin, Jiayun
    Li, Hongjie
    Zheng, Lei
    Zhang, Chihao
    Qi, Xiaoliang
    Huo, Haizhong
    Lou, Xiaolou
    Fan, Qiang
    Bao, Yongyang
    Luo, Meng
    [J]. CANCER CELL INTERNATIONAL, 2021, 21 (01)